ON THE ROLE OF PHARMACOKINETICS IN INTEGRATING RESULTS FROM INVIVO AND INVITRO STUDIES

被引:7
作者
GILLETTE, JR
机构
关键词
D O I
10.1016/0278-6915(86)90170-5
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
引用
收藏
页码:711 / 720
页数:10
相关论文
共 17 条
[1]  
BARON J, 1983, BIOL BASIS DETOXICAT, P105
[2]  
BISCHOFF KB, 1975, CANCER CHEMOTH REP 1, V59, P777
[3]  
CONWAY JG, 1984, MOL PHARMACOL, V25, P487
[4]  
DEDRICK RL, 1980, FED PROC, V39, P54
[5]  
GIBALDI M, 1975, PHARMACOKINETICS
[6]  
Gillette J.R., 1984, PHARMACOKINETICS MOD, P235
[7]  
GILLETTE JR, 1985, BIOACTIVATION FOREIG, P29
[8]  
GILLETTE JR, 1984, DRUG METABOLISM DRUG
[9]  
HJELLE JJ, 1985, DRUG METAB DISPOS, V13, P35
[10]   THEORETICAL RELATIONSHIP BETWEEN DOSE ELIMINATION RATE AND DURATION OF PHARMACOLOGIC EFFECT OF DRUGS [J].
LEVY, G ;
NELSON, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (05) :812-&